Automated Synthesis of [18F]Fluoromethylcholine for Positron-Emission Tomography Imaging


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Automated technology for synthesizing [18F]fluoromethylcholine, a radiopharmaceutical for diagnostic positron-emission-tomography tumor imaging, was developed. A TRACERlab FXFN synthesis module (GE Healthcare) used the combined technology of on-line alkylation and solid-phase extraction. The synthesis module was modified to allow operation at various He flow rates in critical process steps. The radiochemical yield of [18F]fluoromethylcholine was >10%, which was sufficient to produce several clinical doses. The quality control parameters of the produced [18F]fluoromethylcholine met the requirements of the RF Pharmacopoeia.

作者简介

O. Fedorova

N. P. Bekhtereva Institute of Human Brain, Russian Academy of Sciences; St. Petersburg State University

编辑信件的主要联系方式.
Email: fedorova@ihb.spb.ru
俄罗斯联邦, St. Petersburg, 197376; St. Petersburg, 199034

F. Vaitekhovich

GE Healthcare Co.

Email: fedorova@ihb.spb.ru
俄罗斯联邦, Moscow, 123317

R. Krasikova

N. P. Bekhtereva Institute of Human Brain, Russian Academy of Sciences; St. Petersburg State University

Email: fedorova@ihb.spb.ru
俄罗斯联邦, St. Petersburg, 197376; St. Petersburg, 199034


版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2018
##common.cookie##